Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)

null Germany has Released a tender for Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01) in Healthcare and Medicine. The tender was released on Feb 14, 2024.

Country - Germany

Summary - Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)

Deadline - Mar 31, 2025

GT reference number - 78310870

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 78310870

  Document Type - Tender Notices

Notice Details and Documents:

Description - Tender Notice are invited for Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01). The Tender Notice has been released by null and the deadline is 2025-03-31.

Gt Ref Id - 78310870

Deadline - Mar 31, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database